CPB
24
2
INTU
54
3
HP
45
4
L
64
2
AMGN
38
-6
MAR
65
2
BIIB
28
2
NKE
30
2
ABT
62
5
UNP
45
6
AIV
70
2
IVZ
48
2
WDC
43
2
DHR
38
3
EMN
56
7
GM
68
3
BRK.B
42
2
MTB
65
2
APH
67
3
MAS
56
5
CPB
24
2
INTU
54
3
HP
45
4
L
64
2
AMGN
38
-6
MAR
65
2
BIIB
28
2
NKE
30
2
ABT
62
5
UNP
45
6
AIV
70
2
IVZ
48
2
WDC
43
2
DHR
38
3
EMN
56
7
GM
68
3
BRK.B
42
2
MTB
65
2
APH
67
3
MAS
56
5
Financhill
Back

Ultragenyx Pharmaceutical Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
28

RARE
Ultragenyx Pharmaceutical

Last Price:
46.00
Seasonality Move:
12.78%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
246.88
Seasonality Move:
10.85%
Sell
28
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $46.02. The Score for RARE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $246.80. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $46.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $246.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 34.61 Sell
Chaikin Money Flow: -427472 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.13 - 53.99) Sell
Bollinger Bands (100): (46.11 - 56.71) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.62 Sell
Relative Strength Index (14 RSI): 38.74 Sell
Chaikin Money Flow: -304936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (252.02 - 290.24) Sell
Bollinger Bands (100): (248.77 - 281.71) Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.28 Sell
20-day SMA: 49.45 Sell
50-day SMA: 53.38 Sell
200-day SMA: 48.05 Sell
8-day EMA: 46.62 Sell
20-day EMA: 48.96 Sell
50-day EMA: 51.25 Sell
200-day EMA: 48.71 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 248.63 Sell
20-day SMA: 265.26 Sell
50-day SMA: 272.83 Sell
200-day SMA: 211.25 Buy
8-day EMA: 249.36 Sell
20-day EMA: 260.88 Sell
50-day EMA: 266.13 Sell
200-day EMA: 230.89 Buy

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $1.17 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):